{"url_path":"/sec/apus/8-k/2026-07-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-13","source_url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-077591-index.html","accession_number":"0001213900-26-077591","cik":"0001894525","ticker":"APUS","issuer_name":"Apimeds Pharmaceuticals US, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-077591-index.html","primary_entity_key":"0001894525","primary_entity_name":"Apimeds Pharmaceuticals US, Inc."},"word_count":77,"has_tables":true,"body_markdown":"**Item 9.01 Financial\nStatements and Exhibits.**\n\n \n\n**(d) Exhibits.**\n\n \n\n**Exhibit No.**\n \n**Description**\n\n104\n \nCover Page Interactive Data File (embedded within the inline XBRL document)\n\n** **\n\n1\n\n \n\n** **\n\n**SIGNATURE**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\n \nApimeds Pharmaceuticals US, Inc.\n\n \n \n\nDate: July 13, 2026\nBy:\n */s/ Dr. Vin Menon*\n\n \nName:\nDr. Vin Menon\n\n \nTitle:\nChief Executive Officer\n\n \n\n2"}